Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 4-Benzothiazolol

4-Benzothiazolol

4-Benzothiazolol structure

4-Benzothiazolol 

structure
  • CAS No:

    7405-23-4

  • Formula:

    C7H5NOS

  • Chemical Name:

    4-Benzothiazolol

  • Synonyms:

    NSC 403244;4-Benzothiazolol;Benzothiazol-4-ol;benzo[d]thiazol-4-ol;1,3-benzothiazol-4-ol;4-hydroxy-benzothiazol;4-hydroxybenzothiazole;4-Benzothiazolol(6CI,8CI,9CI);4-Benzothiazolol(saMeasBTA-4-0651)

4-Benzothiazolol Basic Attributes

151.1857

151.009186

403244

DTXSID60224947

2934200090

Characteristics

61.4

2

1.4±0.1 g/cm3

143℃

312℃

142℃

1.745

Drug Information

4-hydroxybenzothiazole

4-Benzothiazolol Use and Manufacturing

4-Hydroxy-benzothiazole Boron bromide (3. 09ML, 1M solution in DCM, 3.09 mmol) was added dropwise at 0 C to a stirred solution OF 4-METHOXY-BENZOTHIAZOLE (510 mg, 3.09 mmol) in dry DCM (30ML). The resulting solution was warmed to 40 C and allowed to stir overnight. The resulting solution was concentrated IIZ vacuo and diluted with water and HCl (2N). The aqueous phase was neutralised to pH-7 with NaHC03 and the solution extracted with EtOAc (3 x 100 ml) and the combined organic extracts dried (MGS04) and the solvent removed III vacuo. The resulting oil was purified by flash chromatography eluting silica gel with hexane: EtOAc [4: 1] to hexane: EtOAc [7: 3] to give the title compound as a tan solid (730mg, 80percent) ; ON (300 MHz, CDC13) 7.59 (1H, s, C$, 7.46 (1H, dd, Ar), 7.36 (1H, t, Ar), 7.02 (1H, dd, Ar).b) 4-Hydroxy-benzothiazole Boron tribromide (3. 09m1, 1M solution in DCM, 3.09 mmol) was added dropwise at 0 C to a stirred solution of 4-methoxy-benzothiazole (510 mg, 3.09 mmol) in dry DCM (30MOL). The resulting solution was warmed to 40 C and allowed to stir overnight. The resulting solution was concentrated in vacuo and diluted with water and HCl (2N). The aqueous phase was neutralised to PH-7 with NAHCO3 and the solution extracted with EtOAc (3 x 100 ml) and the combined organic extracts dried (MGS04) and the solvent removed in vacuo. The resulting oil was purified by flash chromatography eluting silica gel with hexane: EtOAc [4 : 1] to hexane: EtOAc [7: 3] to give the title compound as a tan solid (730mg, 80percent) ; BH (300 MHz, CDCL3) 7.59 (1H, s, CH), 7. 46 (1H, dd, Ar), 7.36 (1H, t, Ar), 7.02 (1H, dd, Ar).Boron tribromide (3. 09ML, 1M solution in DCM, 3.09 mmol) was added dropwise at 0 °C to a stirred solution of 4-methoxy-benzothiazole (510 mg, 3.09 mmol) in dry DCM (30ML). The resulting solution was warmed to 40 °C and allowed to stir overnight. The resulting solution was concentrated in vacuo and diluted with water and HCl (2N). The aqueous phase was neutralised to pH-7 with NAHCO3 and the solution extracted with EtOAc (3 x 100 ml) and the combined organic extracts dried (MGS04) and the solvent removed in vacuo. The resulting oil was purified by flash chromatography eluting silica gel with hexane: EtOAc [4: 1] to hexane: EtOAc [7: 3] to give the title compound as a tan solid (730mg, 80percent) ; ON (300 MHz, CDC13) 7.59 (1H, s, CH), 7.46 (1H, dd, Ar), 7.36 (1H, t, Ar), 7.02 (1H, dd, Ar)To a stirred solution of terf-butyl 3-((methylsulfonyl)oxy)azetidine-1 -carboxylate (Intermediate 1) (1 .47 g, 5.85 mmol) and To a stirred solution of tert-butyl 2-methyl-3-((methylsulfonyl)oxy)azetidine-1- carboxylate (Intermediate 99A) (184 mg, 0.693 mmol) and To a stirred solution of tert-butyl 2-methyl-3-((methylsulfonyl)oxy)azetidine-1 - carboxylate (Intermediate 99A) (1 .40 g, 5.28 mmol) and Triphenylphosphine (9.72 g, 37.0 mmol) was added to a solution of benzo[d]thiazol-4- ol (4.00 g, 26.5 mmol) in tetrahydrofuran (80 ml_). The reaction mixture was cooled to 0 °C, and (c/s)-methyl 3-hydroxycyclobutanecarboxylate (4.13 g, 31 .7 mmol) was added, followed by the dropwise addition of DIAD (7.20 ml_, 37.0 mmol). The reaction mixture was then warmed to room temperature, stirred over the weekend, and concentrated. The remaining material was purified on silica gel eluting with a 15percent-60percent EtOAc-hexanes gradient. The appropriate fractions were combined, evaporated under reduced pressure and placed in vacuo to give the title compound (6.72 g, 90percent) which contained about 1 .1 equivalent of reduced DIAD contaminant. 1H NMR (400 MHz, CD3SOCD3) delta 2.51 -2.67 (m, 2 H), 2.75 (td, J = 7, 4 Hz, 2H), 3.10-3.19 (m, 1 H), 3.67 (s, 3 H), 5.03-5.10 (m, 1 H), 6.68 (d, J = 8 Hz, 1 H), 7.26 (t, J = 8 Hz, 1 H), 7.45 (d, J = 8 Hz, 1 H), 8.84 (s, 1 H); LC-MS (LC-ES) M+H = 264.

Computed Properties

Molecular Weight:151.19
XLogP3:2
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:3
Exact Mass:151.00918496
Monoisotopic Mass:151.00918496
Topological Polar Surface Area:61.4
Heavy Atom Count:10
Complexity:131
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.